Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 生化科學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99647
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor張茂山zh_TW
dc.contributor.advisorMau-Sun Changen
dc.contributor.author張育瑄zh_TW
dc.contributor.authorYu-Shiuan Changen
dc.date.accessioned2025-09-17T16:15:19Z-
dc.date.available2025-09-18-
dc.date.copyright2025-09-17-
dc.date.issued2025-
dc.date.submitted2025-08-08-
dc.identifier.citation1 S. Qiu, J. Cai, Z. Yang, X. He, Z. Xing, J. Zu, E. Xie, L. Henry, C.R. Chong, E.M. John, R. Cheung, F. Ji and M.H. Nguyen, JAMA Network Open 7, e2445525-e2445525 (2024) doi: 10.1001/jamanetworkopen.2024.45525
2 F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram and A. Jemal, CA: A Cancer Journal for Clinicians 74, 229-263 (2024) doi: https://doi.org/10.3322/caac.21834
3 E.Y. Tan, P. Danpanichkul, J.N. Yong, Z. Yu, D.J.H. Tan, W.H. Lim, B. Koh, R.Y.Z. Lim, E.K.J. Tham, K. Mitra, A. Morishita, Y.C. Hsu, J.D. Yang, H. Takahashi, M.H. Zheng, A. Nakajima, C.H. Ng, K. Wijarnpreecha, M.D. Muthiah, A.G. Singal and D.Q. Huang, J Hepatol 82, 851-860 (2025) doi: 10.1016/j.jhep.2024.10.031
4 J.D. Yang, P. Hainaut, G.J. Gores, A. Amadou, A. Plymoth and L.R. Roberts, Nat Rev Gastroenterol Hepatol 16, 589-604 (2019) doi: 10.1038/s41575-019-0186-y
5 J. Zhang, M. Yao, S. Xia, F. Zeng and Q. Liu, Cell Mol Biol Lett 30, 2 (2025) doi: 10.1186/s11658-024-00682-7
6 S. Zhao and W.S. El-Deiry, Oncotarget 12, 1970-1979 (2021) doi: 10.18632/oncotarget.28081
7 Y. Zhao, C. Xing, Y. Deng, C. Ye and H. Peng, Genes Dis 11, 234-251 (2024) doi: 10.1016/j.gendis.2023.02.039
8 M. Basheeruddin and S. Qausain, Cureus 16, e70700 (2024) doi: 10.7759/cureus.70700
9 Y. Shi and D.M. Gilkes, Cell Mol Life Sci 82, 44 (2025) doi: 10.1007/s00018-024-05537-0
10 G.N. Masoud and W. Li, Acta Pharm Sin B 5, 378-389 (2015) doi: 10.1016/j.apsb.2015.05.007
11 R.A. Qannita, A.I. Alalami, A.A. Harb, S.M. Aleidi, J. Taneera, E. Abu-Gharbieh, W. El-Huneidi, M.A. Saleh, K.H. Alzoubi, M.H. Semreen, M. Hudaib and Y. Bustanji, Pharmaceuticals 17, 195 (2024)
12 X.M. Li, Z.Y. Zhao, X. Yu, Q.D. Xia, P. Zhou, S.G. Wang, H.L. Wu and J. Hu, Exp Hematol Oncol 12, 34 (2023) doi: 10.1186/s40164-023-00394-2
13 Z. Li, W. Zhou, Y. Zhang, W. Sun, M.M.H. Yung, J. Sun, J. Li, C.W. Chen, Z. Li, Y. Meng, J. Chai, Y. Zhou, S.S. Liu, A.N.Y. Cheung, H.Y.S. Ngan, D.W. Chan, W. Zheng and W. Zhu, Clin Cancer Res 25, 5947-5960 (2019) doi: 10.1158/1078-0432.Ccr-18-4145
14 K. Koukoulas, A. Giakountis, A. Karagiota, M. Samiotaki, G. Panayotou, G. Simos and I. Mylonis, Mol Oncol 15, 3468-3489 (2021) doi: 10.1002/1878-0261.13080
15 I. Mylonis, G. Chachami, E. Paraskeva and G. Simos, Journal of Biological Chemistry 283, 27620-27627 (2008) doi: 10.1074/jbc.M803081200
16 H.S. Kim, Y.H. Kang, J. Lee, S.R. Han, D.B. Kim, H. Ko, S. Park and M.S. Lee, Mol Cells 44, 710-722 (2021) doi: 10.14348/molcells.2021.0093
17 A. Sharma, S. Sinha and N. Shrivastava, Front Genet 13, 849040 (2022) doi: 10.3389/fgene.2022.849040
18 M.Y. Koh, B.G. Darnay and G. Powis, Mol Cell Biol 28, 7081-7095 (2008) doi: 10.1128/mcb.00773-08
19 W. Zhang, X. Shi, Y. Peng, M. Wu, P. Zhang, R. Xie, Y. Wu, Q. Yan, S. Liu and J. Wang, PLOS ONE 10, e0129603 (2015) doi: 10.1371/journal.pone.0129603
20 M. Springer, Z.A. Burakgazi, A. Domukhovska, B. Nafchi, M.C. Beary, A. Acquisto, J. Acquisto, V. Komarov, M. Jensen, B. Gulledge, M. Poplavskyi, M.G. Uddin, G. Rayan and S.N. Zucker, International Journal of Molecular Sciences 26, 5101 (2025)
21 R. Schietke, C. Warnecke, I. Wacker, J. Schödel, D.R. Mole, V. Campean, K. Amann, M. Goppelt-Struebe, J. Behrens, K.-U. Eckardt and M.S. Wiesener, Journal of Biological Chemistry 285, 6658-6669 (2010) doi: https://doi.org/10.1074/jbc.M109.042424
22 A.E. Davies, M. Pargett, S. Siebert, T.E. Gillies, Y. Choi, S.J. Tobin, A.R. Ram, V. Murthy, C. Juliano, G. Quon, M.J. Bissell and J.G. Albeck, Cell Systems 11, 161-175.e165 (2020) doi: https://doi.org/10.1016/j.cels.2020.07.004
23 R. Yakubov, R. Kaloti, P. Persaud, A. McCracken, G. Zadeh and S. Bunda, Journal of Neuro-Oncology 172, 327-345 (2025) doi: 10.1007/s11060-024-04930-w
24 G.N. Masoud and W. Li, Acta Pharmaceutica Sinica B 5, 378-389 (2015) doi: https://doi.org/10.1016/j.apsb.2015.05.007
25 Y. Shi and D.M. Gilkes, Cellular and Molecular Life Sciences 82, 44 (2025) doi: 10.1007/s00018-024-05537-0
26 M.K. Ahmad, N.A. Abdollah, N.H. Shafie, N.M. Yusof and S.R.A. Razak, Cancer Biol Med 15, 14-28 (2018) doi: 10.20892/j.issn.2095-3941.2017.0107
27 J. Kučera, J. Netušilová, S. Sladeček, M. Lánová, O. Vašíček, K. Štefková, J. Navrátilová, L. Kubala and J. Pacherník, Oxid Med Cell Longev 2017, 4386947 (2017) doi: 10.1155/2017/4386947
28 O. Bermudez, G. Pagès and C. Gimond, Am J Physiol Cell Physiol 299, C189-202 (2010) doi: 10.1152/ajpcell.00347.2009
29 K.B. Chiappinelli, B.J. Rimel, L.S. Massad and P.J. Goodfellow, Gynecol Oncol 119, 146-150 (2010) doi: 10.1016/j.ygyno.2010.06.015
30 M.R. Patysheva, E.A. Prostakishina, A.A. Budnitskaya, O.D. Bragina and J.G. Kzhyshkowska, Int J Mol Sci 24, (2023) doi: 10.3390/ijms242417542
31 Y. Ren, Z. Ouyang, Z. Hou, Y. Yan, Z. Zhi, M. Shi, M. Du, H. Liu, Y. Wen and Y. Shao, iScience 23, (2020) doi: 10.1016/j.isci.2020.101635
32 C. Buffet, K. Hecale-Perlemoine, L. Bricaire, F. Dumont, C. Baudry, F. Tissier, J. Bertherat, B. Cochand-Priollet, M.-L. Raffin-Sanson, F. Cormier and L. Groussin, PLOS ONE 12, e0184861 (2017) doi: 10.1371/journal.pone.0184861
33 A. Kucharska, L.K. Rushworth, C. Staples, N.A. Morrice and S.M. Keyse, Cell Signal 21, 1794-1805 (2009) doi: 10.1016/j.cellsig.2009.07.015
34 L.K. Rushworth, A.M. Kidger, L. Delavaine, G. Stewart, S. van Schelven, J. Davidson, C.J. Bryant, E. Caddye, P. East, C.J. Caunt and S.M. Keyse, Proc Natl Acad Sci U S A 111, 18267-18272 (2014) doi: 10.1073/pnas.1420159112
35 L. Zhang, J. Cao, L. Dong and H. Lin, Proceedings of the National Academy of Sciences 117, 13447-13456 (2020) doi: doi:10.1073/pnas.1921815117
36 J.Y. Lee, C.C. Fan, N.L. Chou, H.W. Lin and M.S. Chang, PLoS One 15, e0236876 (2020) doi: 10.1371/journal.pone.0236876
37 A. Ettahar, O. Ferrigno, M.Z. Zhang, M. Ohnishi, N. Ferrand, C. Prunier, L. Levy, M.F. Bourgeade, I. Bieche, D.G. Romero, F. Colland and A. Atfi, Cell Rep 4, 530-541 (2013) doi: 10.1016/j.celrep.2013.07.009
38 H.W. Lin, T.W. Shih, A. Amanna and M.S. Chang, Anticancer Res 43, 5437-5446 (2023) doi: 10.21873/anticanres.16747
39 H.W. Lin, P.Y. Lee, Y.S. Chang and M.S. Chang, Oncol Res 33, 493-503 (2025) doi: 10.32604/or.2024.053791
40 M.A. Mikeladze, E.A. Dutysheva, V.G. Kartsev, B.A. Margulis, I.V. Guzhova and V.F. Lazarev, Int J Mol Sci 22, (2021) doi: 10.3390/ijms22041520
41 S. Courtois-Cox, S.M. Genther Williams, E.E. Reczek, B.W. Johnson, L.T. McGillicuddy, C.M. Johannessen, P.E. Hollstein, M. MacCollin and K. Cichowski, Cancer Cell 10, 459-472 (2006) doi: 10.1016/j.ccr.2006.10.003
42 J.C. Acosta and J. Gil, Trends Cell Biol 22, 211-219 (2012) doi: 10.1016/j.tcb.2011.11.006
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99647-
dc.description.abstract肝細胞癌(Hepatocellular carcinoma, HCC)是全球最常見的原發性肝癌,其惡性進展與腫瘤內部缺氧微環境密切相關。缺氧可穩定並活化轉錄因子HIF1α,促進腫瘤細胞的存活、轉移與血管新生。近年研究指出,ERK訊號傳導可透過磷酸化作用提升HIF1α的穩定性,而DUSP6作為其負向調控因子,可能抑制此途徑活性。PHRF1為具有E3泛素連接酶活性的蛋白,可參與DNA修復與表觀遺傳調節,亦可能具腫瘤抑制功能,惟其在肝癌細胞低氧反應中的角色尚未明確。初步觀察發現,PHRF1缺失的小鼠肝癌細胞在低氧條件下會導致HIF1α顯著上升,顯示PHRF1可能參與HIF1α負向調控。因此本研究探討PHRF1於低氧環境中對HIF1α穩定性與表現的影響,並研究其是否透過ERK/DUSP6路徑進行調控。結果顯示,PHRF1缺失提升HIF1α與pERK蛋白量表現,同時抑制DUSP6,並促進細胞在正常氧氣環境下的EMT與遷移能力,但在低氧下此能力反而下降。儘管HIF1α上升,PHRF1缺失細胞的增殖能力仍顯著降低,顯示其可能具有HIF1α非依賴性的功能,或過度HIF1α活化引發細胞壓力反應,抑制細胞功能。綜合以上結果,我們推測PHRF1可能透過ERK/DUSP6途徑參與HIF1α的調控,影響肝癌細胞對低氧狀態下的適應行為。zh_TW
dc.description.abstractHepatocellular carcinoma (HCC) is the most common form of primary liver cancers worldwide, with poor prognosis and strong association with hypoxic tumor microenvironments. Hypoxia stabilizes and activates the transcription factor HIF1α, promoting tumor cell survival, migration/invasion, metastasis, and angiogenesis. Recent studies suggest that ERK signaling enhances HIF1α stability via phosphorylation of HIF1α, while DUSP6 acts as a negative regulator to dephosphorylate ERK pathway. PHRF1 is an E3 ubiquitin ligase involved in DNA repair and epigenetic regulation. However, the role of PHRF1 in liver cancer remains unclear. Preliminary observations showed that PHRF1 knockout under hypoxic conditions leads to increased HIF1α protein expression, implying a negative regulatory role of PHRF1 in HIF1α regulation. This study aims to study how PHRF1 regulated HIF1α expression and stability under hypoxia condition, and whether ERK/DUSP6 pathway was also affected in the absence of PHRF1. Our results revealed that PHRF1 deficiency elevated HIF1α and phosphorylated ERK (pERK) levels while the amount of DUSP6 was decreased under hypoxia. The expression of epithelial–mesenchymal transition (EMT) markers and cell migration ability were elevated under normoxia but reduced under hypoxia. Despite elevated HIF1α levels, PHRF1-deficient cells exhibited impaired clonogenic formation, suggesting that PHRF1 may regulate this process through HIF1α-independent mechanisms or through stress responses triggered by excessive HIF1α activity. Collectively, these findings indicate that PHRF1 may modulate HIF1α through the ERK/DUSP6 axis and influence hypoxia adaptation and malignancy in HCC cells.en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-17T16:15:19Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2025-09-17T16:15:19Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents致謝 I
中文摘要 II
Abstract III
圖次 VI
表次 VII
第一章 前言 1
1.1 研究背景 1
1.2 缺氧誘導因子HIF1的角色 1
1.3 ERK訊息傳導途徑與HIF1α穩定性 3
1.4 DUSP於訊息傳遞中的負向調控角色 4
1.5 PHRF1的功能與潛在角色 4
1.6 研究動機與目的 6
第二章 實驗材料與方法 7
2.1 CoCl2處理液 7
2.2 細胞培養(Cell Culture) 7
2.2.1 小鼠初代培養 7
2.2.2. 細胞培養 7
2.3 低氧檢測分析(Hypoxia Detection Assay) 7
2.4 CoCl2 treatment assay 8
2.5 蛋白定量及西方墨點法(Western Blot) 8
2.6 CCK-8細胞增殖分析 10
2.7 集落形成實驗(Colony Formation) 10
2.8 傷口癒合實驗(Wound Healing Assay) 11
2.9 細胞侵襲實驗(Invasion Assay) 11
第三章 實驗結果 13
第四章 總結與討論 19
參考文獻 38
-
dc.language.isozh_TW-
dc.subjectHIF1αzh_TW
dc.subject低氧環境zh_TW
dc.subjectDUSP6zh_TW
dc.subjectERKzh_TW
dc.subjectPHRF1zh_TW
dc.subjectPHRF1en
dc.subjectERKen
dc.subjectDUSP6en
dc.subjectHIF1αen
dc.subjecthypoxiaen
dc.title缺乏PHRF1表現的小鼠肝癌細胞在低氧條件下影響HIF1α蛋白總量的機制探討zh_TW
dc.titlePHRF1 Deficiency Modulates HIF1α Protein in Response to Hypoxia in Mouse Liver Cancer Cellsen
dc.typeThesis-
dc.date.schoolyear113-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee蕭超隆;張瀞仁zh_TW
dc.contributor.oralexamcommitteeChiao-Long Hsiao;Ching-Jin Changen
dc.subject.keyword低氧環境,HIF1α,PHRF1,ERK,DUSP6,zh_TW
dc.subject.keywordhypoxia,HIF1α,PHRF1,ERK,DUSP6,en
dc.relation.page42-
dc.identifier.doi10.6342/NTU202501753-
dc.rights.note同意授權(限校園內公開)-
dc.date.accepted2025-08-12-
dc.contributor.author-college生命科學院-
dc.contributor.author-dept生化科學研究所-
dc.date.embargo-lift2027-08-01-
顯示於系所單位:生化科學研究所

文件中的檔案:
檔案 大小格式 
ntu-113-2.pdf
  未授權公開取用
2.86 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved